Cargando…
Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359150/ https://www.ncbi.nlm.nih.gov/pubmed/32447548 http://dx.doi.org/10.1007/s00415-020-09919-9 |
_version_ | 1783558988870189056 |
---|---|
author | Jayaprakash, Kiran Glasmacher, Stella A. Pang, Bernard Beswick, Emily Mehta, Arpan R. Dakin, Rachel Newton, Judith Chandran, Siddharthan Pal, Suvankar |
author_facet | Jayaprakash, Kiran Glasmacher, Stella A. Pang, Bernard Beswick, Emily Mehta, Arpan R. Dakin, Rachel Newton, Judith Chandran, Siddharthan Pal, Suvankar |
author_sort | Jayaprakash, Kiran |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7359150 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-73591502020-07-16 Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland Jayaprakash, Kiran Glasmacher, Stella A. Pang, Bernard Beswick, Emily Mehta, Arpan R. Dakin, Rachel Newton, Judith Chandran, Siddharthan Pal, Suvankar J Neurol Letter to the Editors Springer Berlin Heidelberg 2020-05-23 2020 /pmc/articles/PMC7359150/ /pubmed/32447548 http://dx.doi.org/10.1007/s00415-020-09919-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Letter to the Editors Jayaprakash, Kiran Glasmacher, Stella A. Pang, Bernard Beswick, Emily Mehta, Arpan R. Dakin, Rachel Newton, Judith Chandran, Siddharthan Pal, Suvankar Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland |
title | Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland |
title_full | Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland |
title_fullStr | Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland |
title_full_unstemmed | Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland |
title_short | Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland |
title_sort | riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in scotland |
topic | Letter to the Editors |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359150/ https://www.ncbi.nlm.nih.gov/pubmed/32447548 http://dx.doi.org/10.1007/s00415-020-09919-9 |
work_keys_str_mv | AT jayaprakashkiran riluzoleprescribinguptakeandtreatmentdiscontinuationinpeoplewithamyotrophiclateralsclerosisinscotland AT glasmacherstellaa riluzoleprescribinguptakeandtreatmentdiscontinuationinpeoplewithamyotrophiclateralsclerosisinscotland AT pangbernard riluzoleprescribinguptakeandtreatmentdiscontinuationinpeoplewithamyotrophiclateralsclerosisinscotland AT beswickemily riluzoleprescribinguptakeandtreatmentdiscontinuationinpeoplewithamyotrophiclateralsclerosisinscotland AT mehtaarpanr riluzoleprescribinguptakeandtreatmentdiscontinuationinpeoplewithamyotrophiclateralsclerosisinscotland AT dakinrachel riluzoleprescribinguptakeandtreatmentdiscontinuationinpeoplewithamyotrophiclateralsclerosisinscotland AT newtonjudith riluzoleprescribinguptakeandtreatmentdiscontinuationinpeoplewithamyotrophiclateralsclerosisinscotland AT chandransiddharthan riluzoleprescribinguptakeandtreatmentdiscontinuationinpeoplewithamyotrophiclateralsclerosisinscotland AT palsuvankar riluzoleprescribinguptakeandtreatmentdiscontinuationinpeoplewithamyotrophiclateralsclerosisinscotland AT riluzoleprescribinguptakeandtreatmentdiscontinuationinpeoplewithamyotrophiclateralsclerosisinscotland |